

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 7.81604545 |
| 2 | doxorubicin metabolic process (GO:0044598) | 7.81604545 |
| 3 | daunorubicin metabolic process (GO:0044597) | 7.81604545 |
| 4 | angiotensin maturation (GO:0002003) | 6.18289171 |
| 5 | hormone catabolic process (GO:0042447) | 5.88780336 |
| 6 | coenzyme catabolic process (GO:0009109) | 5.68647733 |
| 7 | diacylglycerol metabolic process (GO:0046339) | 5.63901780 |
| 8 | NADH metabolic process (GO:0006734) | 5.63691035 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 5.29349316 |
| 10 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.25493308 |
| 11 | cellular modified amino acid catabolic process (GO:0042219) | 5.24059342 |
| 12 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.14064435 |
| 13 | epoxygenase P450 pathway (GO:0019373) | 5.10050977 |
| 14 | regulation of guanylate cyclase activity (GO:0031282) | 5.02839729 |
| 15 | negative regulation of epidermis development (GO:0045683) | 4.87717906 |
| 16 | somite rostral/caudal axis specification (GO:0032525) | 4.77743491 |
| 17 | desmosome organization (GO:0002934) | 4.75255584 |
| 18 | low-density lipoprotein particle clearance (GO:0034383) | 4.50724985 |
| 19 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.47066083 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.33355988 |
| 21 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.31900351 |
| 22 | muscle organ morphogenesis (GO:0048644) | 4.26097219 |
| 23 | regulation of bile acid biosynthetic process (GO:0070857) | 4.25997689 |
| 24 | maintenance of protein location in nucleus (GO:0051457) | 4.25675127 |
| 25 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.20148640 |
| 26 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.19600900 |
| 27 | vitamin A metabolic process (GO:0006776) | 4.17806310 |
| 28 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.16267787 |
| 29 | vitamin transmembrane transport (GO:0035461) | 4.15900937 |
| 30 | primary alcohol catabolic process (GO:0034310) | 4.12600893 |
| 31 | regulation of response to osmotic stress (GO:0047484) | 4.09655568 |
| 32 | plasma lipoprotein particle assembly (GO:0034377) | 4.02286597 |
| 33 | GDP-mannose metabolic process (GO:0019673) | 3.99345439 |
| 34 | flavonoid metabolic process (GO:0009812) | 3.98588807 |
| 35 | intestinal cholesterol absorption (GO:0030299) | 3.98186930 |
| 36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.97831529 |
| 37 | L-phenylalanine metabolic process (GO:0006558) | 3.97831529 |
| 38 | lipoprotein transport (GO:0042953) | 3.97624371 |
| 39 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.93704539 |
| 40 | nucleoside transmembrane transport (GO:1901642) | 3.90189442 |
| 41 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.85612830 |
| 42 | triglyceride biosynthetic process (GO:0019432) | 3.84817284 |
| 43 | cellular glucuronidation (GO:0052695) | 3.84795402 |
| 44 | drug metabolic process (GO:0017144) | 3.84228685 |
| 45 | transcytosis (GO:0045056) | 3.81569073 |
| 46 | heme transport (GO:0015886) | 3.80354767 |
| 47 | intestinal absorption (GO:0050892) | 3.80303635 |
| 48 | L-phenylalanine catabolic process (GO:0006559) | 3.80095027 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.80095027 |
| 50 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.73788004 |
| 51 | glucuronate metabolic process (GO:0019585) | 3.73033631 |
| 52 | uronic acid metabolic process (GO:0006063) | 3.73033631 |
| 53 | cytidine deamination (GO:0009972) | 3.72914478 |
| 54 | cytidine metabolic process (GO:0046087) | 3.72914478 |
| 55 | cytidine catabolic process (GO:0006216) | 3.72914478 |
| 56 | renal system process involved in regulation of blood volume (GO:0001977) | 3.68417378 |
| 57 | regulation of triglyceride catabolic process (GO:0010896) | 3.66497875 |
| 58 | acylglycerol biosynthetic process (GO:0046463) | 3.66437687 |
| 59 | neutral lipid biosynthetic process (GO:0046460) | 3.66437687 |
| 60 | phenol-containing compound catabolic process (GO:0019336) | 3.62313704 |
| 61 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.61085168 |
| 62 | endocrine process (GO:0050886) | 3.61085168 |
| 63 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.61085168 |
| 64 | protein-lipid complex assembly (GO:0065005) | 3.60266120 |
| 65 | cofactor catabolic process (GO:0051187) | 3.60201898 |
| 66 | response to dietary excess (GO:0002021) | 3.59685201 |
| 67 | ethanol oxidation (GO:0006069) | 3.59241202 |
| 68 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.52166959 |
| 69 | proline biosynthetic process (GO:0006561) | 3.49330222 |
| 70 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.48904394 |
| 71 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.48269914 |
| 72 | bile acid and bile salt transport (GO:0015721) | 3.48038364 |
| 73 | high-density lipoprotein particle remodeling (GO:0034375) | 3.47424922 |
| 74 | quinone metabolic process (GO:1901661) | 3.47419195 |
| 75 | aromatic amino acid family catabolic process (GO:0009074) | 3.47052146 |
| 76 | regulation of cholesterol esterification (GO:0010872) | 3.46885812 |
| 77 | triglyceride catabolic process (GO:0019433) | 3.46348185 |
| 78 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.44935905 |
| 79 | positive regulation of lipid catabolic process (GO:0050996) | 3.44134246 |
| 80 | urea metabolic process (GO:0019627) | 3.41853984 |
| 81 | urea cycle (GO:0000050) | 3.41853984 |
| 82 | phenylpropanoid metabolic process (GO:0009698) | 3.41827266 |
| 83 | fructose metabolic process (GO:0006000) | 3.41517944 |
| 84 | cofactor transport (GO:0051181) | 3.41133982 |
| 85 | transepithelial transport (GO:0070633) | 3.40871334 |
| 86 | phospholipid efflux (GO:0033700) | 3.39805466 |
| 87 | omega-hydroxylase P450 pathway (GO:0097267) | 3.38944417 |
| 88 | notochord development (GO:0030903) | 3.38710573 |
| 89 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.35449890 |
| 90 | acylglycerol catabolic process (GO:0046464) | 3.35417073 |
| 91 | neutral lipid catabolic process (GO:0046461) | 3.35417073 |
| 92 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.34458882 |
| 93 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.33385262 |
| 94 | regulation of cholesterol metabolic process (GO:0090181) | 3.33304537 |
| 95 | L-ascorbic acid metabolic process (GO:0019852) | 3.32973570 |
| 96 | primitive streak formation (GO:0090009) | 3.32883551 |
| 97 | glycerol metabolic process (GO:0006071) | 3.32623126 |
| 98 | modified amino acid transport (GO:0072337) | 3.31091318 |
| 99 | thyroid hormone generation (GO:0006590) | 3.30437213 |
| 100 | rRNA transcription (GO:0009303) | 3.30289448 |
| 101 | regulation of cholesterol homeostasis (GO:2000188) | 3.29697348 |
| 102 | regulation of cGMP biosynthetic process (GO:0030826) | 3.29318412 |
| 103 | regulation of systemic arterial blood pressure (GO:0003073) | 3.29295057 |
| 104 | negative regulation of telomerase activity (GO:0051974) | 3.27650623 |
| 105 | positive regulation of pseudopodium assembly (GO:0031274) | 3.26039744 |
| 106 | sphingomyelin metabolic process (GO:0006684) | 3.25384613 |
| 107 | proline metabolic process (GO:0006560) | 3.24292678 |
| 108 | heterochromatin organization (GO:0070828) | 3.23390514 |
| 109 | alpha-linolenic acid metabolic process (GO:0036109) | 3.23349617 |
| 110 | kynurenine metabolic process (GO:0070189) | 3.22948593 |
| 111 | biotin metabolic process (GO:0006768) | 3.19809151 |
| 112 | tryptophan catabolic process (GO:0006569) | 3.19228712 |
| 113 | indole-containing compound catabolic process (GO:0042436) | 3.19228712 |
| 114 | indolalkylamine catabolic process (GO:0046218) | 3.19228712 |
| 115 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.18028585 |
| 116 | cysteine metabolic process (GO:0006534) | 3.16957447 |
| 117 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.16616952 |
| 118 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.14649265 |
| 119 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.14622855 |
| 120 | thyroid hormone metabolic process (GO:0042403) | 3.12614612 |
| 121 | negative regulation of cholesterol transport (GO:0032375) | 3.12474260 |
| 122 | negative regulation of sterol transport (GO:0032372) | 3.12474260 |
| 123 | triglyceride metabolic process (GO:0006641) | 3.12222917 |
| 124 | drug catabolic process (GO:0042737) | 3.11984035 |
| 125 | fat-soluble vitamin metabolic process (GO:0006775) | 3.10334457 |
| 126 | cGMP-mediated signaling (GO:0019934) | 3.09907284 |
| 127 | reverse cholesterol transport (GO:0043691) | 3.08982527 |
| 128 | sulfate transmembrane transport (GO:1902358) | 3.07703496 |
| 129 | very long-chain fatty acid metabolic process (GO:0000038) | 3.07606007 |
| 130 | alditol metabolic process (GO:0019400) | 3.05789660 |
| 131 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.05430887 |
| 132 | ethanol metabolic process (GO:0006067) | 3.05338287 |
| 133 | cholesterol homeostasis (GO:0042632) | 3.05122677 |
| 134 | phospholipid homeostasis (GO:0055091) | 3.04969695 |
| 135 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.04836017 |
| 136 | triglyceride homeostasis (GO:0070328) | 3.04390713 |
| 137 | acylglycerol homeostasis (GO:0055090) | 3.04390713 |
| 138 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.03422555 |
| 139 | valine metabolic process (GO:0006573) | 3.01997994 |
| 140 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.01278158 |
| 141 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.01059341 |
| 142 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.01059341 |
| 143 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.01008866 |
| 144 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.00937316 |
| 145 | nitrogen cycle metabolic process (GO:0071941) | 2.99776320 |
| 146 | glyoxylate metabolic process (GO:0046487) | 2.99631243 |
| 147 | sterol homeostasis (GO:0055092) | 2.99589005 |
| 148 | plasma lipoprotein particle organization (GO:0071827) | 2.99335639 |
| 149 | intestinal epithelial cell development (GO:0060576) | 2.97860661 |
| 150 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.97834174 |
| 151 | serine family amino acid catabolic process (GO:0009071) | 2.97759018 |
| 152 | icosanoid transport (GO:0071715) | 2.96362183 |
| 153 | fatty acid derivative transport (GO:1901571) | 2.96362183 |
| 154 | lipoprotein metabolic process (GO:0042157) | 2.95529810 |
| 155 | protein localization to kinetochore (GO:0034501) | 2.95525171 |
| 156 | nucleoside transport (GO:0015858) | 2.93716918 |
| 157 | acylglycerol metabolic process (GO:0006639) | 2.93653872 |
| 158 | acyl-CoA biosynthetic process (GO:0071616) | 2.93126284 |
| 159 | thioester biosynthetic process (GO:0035384) | 2.93126284 |
| 160 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.93096078 |
| 161 | tryptophan metabolic process (GO:0006568) | 2.92920962 |
| 162 | xenobiotic catabolic process (GO:0042178) | 2.92355921 |
| 163 | plasma lipoprotein particle remodeling (GO:0034369) | 2.91779280 |
| 164 | protein-lipid complex remodeling (GO:0034368) | 2.91779280 |
| 165 | macromolecular complex remodeling (GO:0034367) | 2.91779280 |
| 166 | multicellular organismal water homeostasis (GO:0050891) | 2.89156531 |
| 167 | neutral lipid metabolic process (GO:0006638) | 2.88958071 |
| 168 | plasma lipoprotein particle clearance (GO:0034381) | 2.88416272 |
| 169 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.87386289 |
| 170 | maternal placenta development (GO:0001893) | 2.87063254 |
| 171 | histone H4-K5 acetylation (GO:0043981) | 2.86770035 |
| 172 | response to phenylpropanoid (GO:0080184) | 2.86010989 |
| 173 | fatty acid homeostasis (GO:0055089) | 2.84182092 |
| 174 | arginine metabolic process (GO:0006525) | 2.83451265 |
| 175 | regulation of pseudopodium assembly (GO:0031272) | 2.83194766 |
| 176 | amino-acid betaine transport (GO:0015838) | 2.82824415 |
| 177 | carnitine transport (GO:0015879) | 2.82824415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.94764521 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.33209773 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.33209773 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.33209773 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.63304081 |
| 6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56183183 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.35607501 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.97307881 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.83603489 |
| 10 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.82665146 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.70554726 |
| 12 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.67885005 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.66986841 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.51620019 |
| 15 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.49905160 |
| 16 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.43621883 |
| 17 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.39632797 |
| 18 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.31524986 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.30991417 |
| 20 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.29486215 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.28541846 |
| 22 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.28163820 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.26565887 |
| 24 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.23664289 |
| 25 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.19372198 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.18827150 |
| 27 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.14309863 |
| 28 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.11604274 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.08372137 |
| 30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.98566854 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.93263154 |
| 32 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.92138246 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.90835672 |
| 34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.85045574 |
| 35 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.79605948 |
| 36 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.79361781 |
| 37 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.79224656 |
| 38 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.75743134 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74288771 |
| 40 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71591105 |
| 41 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.69605338 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65600545 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.59492103 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59265899 |
| 45 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.55145070 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.54697288 |
| 47 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.53762882 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53356642 |
| 49 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.50560736 |
| 50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.49447395 |
| 51 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.48277897 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.46723188 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42985997 |
| 54 | ATF3_27146783_Chip-Seq_COLON_Human | 1.42814688 |
| 55 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.42532545 |
| 56 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42302279 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42179331 |
| 58 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.41554937 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39843819 |
| 60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.38071498 |
| 61 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.36663701 |
| 62 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34412568 |
| 63 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.30398294 |
| 64 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.29900335 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29107985 |
| 66 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.28844801 |
| 67 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.27708265 |
| 68 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.27506357 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27094840 |
| 70 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.27028087 |
| 71 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26286521 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26143013 |
| 73 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.24981168 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24889040 |
| 75 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24658595 |
| 76 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.24600329 |
| 77 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23223361 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21683061 |
| 79 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.21544950 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20377946 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20296073 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20083611 |
| 83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20063258 |
| 84 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19991836 |
| 85 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.19739820 |
| 86 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.19678586 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19032526 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18861355 |
| 89 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.18433393 |
| 90 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.17181469 |
| 91 | SA1_27219007_Chip-Seq_Bcells_Human | 1.16575695 |
| 92 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.14666007 |
| 93 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13798943 |
| 94 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13678746 |
| 95 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.12953185 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12885917 |
| 97 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.11130224 |
| 98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10165133 |
| 99 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09718025 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09561923 |
| 101 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.06850070 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06812954 |
| 103 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06609320 |
| 104 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.06523596 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06429770 |
| 106 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05807366 |
| 107 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05160541 |
| 108 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03879483 |
| 109 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.03124844 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02974708 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02124724 |
| 112 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01893014 |
| 113 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.00804325 |
| 114 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00530704 |
| 115 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.99373470 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98985477 |
| 117 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98396983 |
| 118 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97902776 |
| 119 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97206252 |
| 120 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96570987 |
| 121 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.95663708 |
| 122 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94794772 |
| 123 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92651967 |
| 124 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91624591 |
| 125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91272943 |
| 126 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.91091242 |
| 127 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.90303114 |
| 128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90167178 |
| 129 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86884936 |
| 130 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85554979 |
| 131 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.85506422 |
| 132 | MYC_22102868_ChIP-Seq_BL_Human | 0.85403331 |
| 133 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82954108 |
| 134 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.82151933 |
| 135 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.81160249 |
| 136 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80780532 |
| 137 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79595612 |
| 138 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.77885688 |
| 139 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.77005440 |
| 140 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74350323 |
| 141 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.74104363 |
| 142 | P68_20966046_ChIP-Seq_HELA_Human | 0.73735507 |
| 143 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.72218752 |
| 144 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72146976 |
| 145 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71793694 |
| 146 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.70624382 |
| 147 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70582240 |
| 148 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.70342131 |
| 149 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.70201748 |
| 150 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.69991371 |
| 151 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.68815433 |
| 152 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.68794402 |
| 153 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.68680431 |
| 154 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68505719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.38635292 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 5.23173532 |
| 3 | MP0002254_reproductive_system_inflammat | 4.58819016 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.47009846 |
| 5 | MP0003011_delayed_dark_adaptation | 4.44461007 |
| 6 | MP0005670_abnormal_white_adipose | 3.76659666 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.64952239 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.43603998 |
| 9 | MP0005365_abnormal_bile_salt | 3.29099596 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 3.04876354 |
| 11 | MP0005409_darkened_coat_color | 2.67831120 |
| 12 | MP0005666_abnormal_adipose_tissue | 2.64295691 |
| 13 | MP0005075_abnormal_melanosome_morpholog | 2.43987597 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.42568083 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.31688108 |
| 16 | MP0009840_abnormal_foam_cell | 2.28508080 |
| 17 | MP0003252_abnormal_bile_duct | 2.26589719 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.20210691 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.14731322 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 2.05487252 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.05441252 |
| 22 | MP0004858_abnormal_nervous_system | 1.99620244 |
| 23 | MP0002332_abnormal_exercise_endurance | 1.99503988 |
| 24 | MP0005375_adipose_tissue_phenotype | 1.95033034 |
| 25 | MP0000566_synostosis | 1.93734847 |
| 26 | MP0002971_abnormal_brown_adipose | 1.90460767 |
| 27 | MP0003890_abnormal_embryonic-extraembry | 1.89654329 |
| 28 | MP0005499_abnormal_olfactory_system | 1.87291787 |
| 29 | MP0005394_taste/olfaction_phenotype | 1.87291787 |
| 30 | MP0001664_abnormal_digestion | 1.79256601 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.75145371 |
| 32 | MP0002796_impaired_skin_barrier | 1.69409054 |
| 33 | MP0000609_abnormal_liver_physiology | 1.60279361 |
| 34 | MP0005257_abnormal_intraocular_pressure | 1.57523358 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.56860256 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.56467312 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.56020937 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.51738271 |
| 39 | MP0009379_abnormal_foot_pigmentation | 1.51648287 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.51447742 |
| 41 | MP0004147_increased_porphyrin_level | 1.51365042 |
| 42 | MP0001765_abnormal_ion_homeostasis | 1.47854293 |
| 43 | MP0001849_ear_inflammation | 1.44765190 |
| 44 | MP0005332_abnormal_amino_acid | 1.43568785 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 1.42536409 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.41916666 |
| 47 | MP0000003_abnormal_adipose_tissue | 1.41808376 |
| 48 | MP0005451_abnormal_body_composition | 1.37126190 |
| 49 | MP0004043_abnormal_pH_regulation | 1.35861740 |
| 50 | MP0001188_hyperpigmentation | 1.35201816 |
| 51 | MP0003866_abnormal_defecation | 1.34463937 |
| 52 | MP0001756_abnormal_urination | 1.30619489 |
| 53 | MP0001764_abnormal_homeostasis | 1.30353976 |
| 54 | MP0005266_abnormal_metabolism | 1.28681548 |
| 55 | MP0000538_abnormal_urinary_bladder | 1.28555614 |
| 56 | MP0002098_abnormal_vibrissa_morphology | 1.25880694 |
| 57 | MP0006082_CNS_inflammation | 1.25041885 |
| 58 | MP0008961_abnormal_basal_metabolism | 1.24815997 |
| 59 | MP0003122_maternal_imprinting | 1.23863819 |
| 60 | MP0005448_abnormal_energy_balance | 1.20397275 |
| 61 | MP0004130_abnormal_muscle_cell | 1.19803908 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.15259916 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.13748800 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.11836181 |
| 65 | MP0005334_abnormal_fat_pad | 1.11237974 |
| 66 | MP0002118_abnormal_lipid_homeostasis | 1.10818036 |
| 67 | MP0002136_abnormal_kidney_physiology | 1.10363426 |
| 68 | MP0002132_abnormal_respiratory_system | 1.10072905 |
| 69 | MP0005023_abnormal_wound_healing | 1.08525427 |
| 70 | MP0001873_stomach_inflammation | 1.06366501 |
| 71 | MP0000762_abnormal_tongue_morphology | 1.01068337 |
| 72 | MP0002909_abnormal_adrenal_gland | 0.98949736 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 0.98816969 |
| 74 | MP0000598_abnormal_liver_morphology | 0.98811566 |
| 75 | MP0003938_abnormal_ear_development | 0.97660685 |
| 76 | MP0005535_abnormal_body_temperature | 0.96558537 |
| 77 | MP0004957_abnormal_blastocyst_morpholog | 0.95820887 |
| 78 | MP0003879_abnormal_hair_cell | 0.94145075 |
| 79 | MP0004381_abnormal_hair_follicle | 0.93102903 |
| 80 | MP0002092_abnormal_eye_morphology | 0.92767974 |
| 81 | MP0001672_abnormal_embryogenesis/_devel | 0.92590541 |
| 82 | MP0005380_embryogenesis_phenotype | 0.92590541 |
| 83 | MP0000462_abnormal_digestive_system | 0.91489803 |
| 84 | MP0000013_abnormal_adipose_tissue | 0.91049846 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 0.90406884 |
| 86 | MP0002653_abnormal_ependyma_morphology | 0.89951699 |
| 87 | MP0003315_abnormal_perineum_morphology | 0.89439496 |
| 88 | MP0005248_abnormal_Harderian_gland | 0.89175539 |
| 89 | MP0005083_abnormal_biliary_tract | 0.89156206 |
| 90 | MP0009643_abnormal_urine_homeostasis | 0.88912431 |
| 91 | MP0003868_abnormal_feces_composition | 0.88431874 |
| 92 | MP0000537_abnormal_urethra_morphology | 0.87352535 |
| 93 | MP0010368_abnormal_lymphatic_system | 0.87135892 |
| 94 | MP0002970_abnormal_white_adipose | 0.84927787 |
| 95 | MP0002127_abnormal_cardiovascular_syste | 0.84063479 |
| 96 | MP0003984_embryonic_growth_retardation | 0.83826629 |
| 97 | MP0001243_abnormal_dermal_layer | 0.82399292 |
| 98 | MP0006138_congestive_heart_failure | 0.82094641 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.81915265 |
| 100 | MP0003878_abnormal_ear_physiology | 0.81915265 |
| 101 | MP0002932_abnormal_joint_morphology | 0.81635340 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.81564396 |
| 103 | MP0002086_abnormal_extraembryonic_tissu | 0.79892525 |
| 104 | MP0010771_integument_phenotype | 0.79047394 |
| 105 | MP0001881_abnormal_mammary_gland | 0.78910594 |
| 106 | MP0001293_anophthalmia | 0.77707687 |
| 107 | MP0008057_abnormal_DNA_replication | 0.77418224 |
| 108 | MP0010030_abnormal_orbit_morphology | 0.76925935 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 0.76563201 |
| 110 | MP0005501_abnormal_skin_physiology | 0.75780808 |
| 111 | MP0001661_extended_life_span | 0.75134385 |
| 112 | MP0003453_abnormal_keratinocyte_physiol | 0.74859161 |
| 113 | MP0002396_abnormal_hematopoietic_system | 0.74734125 |
| 114 | MP0001663_abnormal_digestive_system | 0.74206975 |
| 115 | MP0002060_abnormal_skin_morphology | 0.73490089 |
| 116 | MP0000377_abnormal_hair_follicle | 0.72664607 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.72662408 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.72299852 |
| 119 | MP0000490_abnormal_crypts_of | 0.71582248 |
| 120 | MP0005166_decreased_susceptibility_to | 0.71547323 |
| 121 | MP0003436_decreased_susceptibility_to | 0.70583050 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.69348077 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.68579148 |
| 124 | MP0001216_abnormal_epidermal_layer | 0.65849895 |
| 125 | MP0000383_abnormal_hair_follicle | 0.65456884 |
| 126 | MP0003953_abnormal_hormone_level | 0.65096893 |
| 127 | MP0003718_maternal_effect | 0.64872143 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.64439143 |
| 129 | MP0003941_abnormal_skin_development | 0.64293047 |
| 130 | MP0000477_abnormal_intestine_morphology | 0.62308648 |
| 131 | MP0006036_abnormal_mitochondrial_physio | 0.60820955 |
| 132 | MP0010678_abnormal_skin_adnexa | 0.60456785 |
| 133 | MP0009115_abnormal_fat_cell | 0.60250986 |
| 134 | MP0003186_abnormal_redox_activity | 0.59140824 |
| 135 | MP0003121_genomic_imprinting | 0.59025817 |
| 136 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58521443 |
| 137 | MP0005058_abnormal_lysosome_morphology | 0.56255311 |
| 138 | MP0008872_abnormal_physiological_respon | 0.56176349 |
| 139 | MP0002009_preneoplasia | 0.55842290 |
| 140 | MP0002233_abnormal_nose_morphology | 0.55245559 |
| 141 | MP0000467_abnormal_esophagus_morphology | 0.55224447 |
| 142 | MP0010155_abnormal_intestine_physiology | 0.55182758 |
| 143 | MP0004947_skin_inflammation | 0.55122865 |
| 144 | MP0000470_abnormal_stomach_morphology | 0.54552144 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.54452024 |
| 146 | MP0004782_abnormal_surfactant_physiolog | 0.53823880 |
| 147 | MP0008770_decreased_survivor_rate | 0.53687688 |
| 148 | MP0009763_increased_sensitivity_to | 0.52682053 |
| 149 | MP0009931_abnormal_skin_appearance | 0.51980873 |
| 150 | MP0002269_muscular_atrophy | 0.50102473 |
| 151 | MP0008789_abnormal_olfactory_epithelium | 0.50000257 |
| 152 | MP0000647_abnormal_sebaceous_gland | 0.49767218 |
| 153 | MP0009764_decreased_sensitivity_to | 0.48844057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 6.26346953 |
| 2 | Bilateral microphthalmos (HP:0007633) | 5.99424268 |
| 3 | Hemorrhage of the eye (HP:0011885) | 5.06750965 |
| 4 | Hepatoblastoma (HP:0002884) | 4.90975214 |
| 5 | Abnormality of proline metabolism (HP:0010907) | 4.80915915 |
| 6 | Hydroxyprolinuria (HP:0003080) | 4.80915915 |
| 7 | Widely patent fontanelles and sutures (HP:0004492) | 4.42790926 |
| 8 | Abnormality of the lower motor neuron (HP:0002366) | 4.38352766 |
| 9 | Multiple enchondromatosis (HP:0005701) | 4.34414188 |
| 10 | Hyperactive renin-angiotensin system (HP:0000841) | 4.30145388 |
| 11 | Ileus (HP:0002595) | 4.11640830 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 4.07845205 |
| 13 | Decreased circulating renin level (HP:0003351) | 3.99363710 |
| 14 | Thin bony cortex (HP:0002753) | 3.96691333 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.88217996 |
| 16 | Ependymoma (HP:0002888) | 3.86795020 |
| 17 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.77724810 |
| 18 | Malnutrition (HP:0004395) | 3.70941891 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.67422811 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.55987339 |
| 21 | Rib fusion (HP:0000902) | 3.54008553 |
| 22 | Hyperglycinuria (HP:0003108) | 3.50845217 |
| 23 | Xanthomatosis (HP:0000991) | 3.48522427 |
| 24 | Pigmentary retinal degeneration (HP:0001146) | 3.44635719 |
| 25 | Abnormality of renin-angiotensin system (HP:0000847) | 3.40731927 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 3.37432824 |
| 27 | Abnormal cartilage morphology (HP:0002763) | 3.36503915 |
| 28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.32334721 |
| 29 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.18485930 |
| 30 | Abnormality of the salivary glands (HP:0010286) | 3.15178730 |
| 31 | Deep venous thrombosis (HP:0002625) | 3.14395165 |
| 32 | Wide cranial sutures (HP:0010537) | 3.11067124 |
| 33 | Rhabdomyosarcoma (HP:0002859) | 3.09855122 |
| 34 | Confusion (HP:0001289) | 3.05711268 |
| 35 | Neoplasm of striated muscle (HP:0009728) | 3.01177343 |
| 36 | Abnormality of vitamin B metabolism (HP:0004340) | 2.94784708 |
| 37 | Skin nodule (HP:0200036) | 2.94333339 |
| 38 | Delayed epiphyseal ossification (HP:0002663) | 2.92803460 |
| 39 | Increased connective tissue (HP:0009025) | 2.88068898 |
| 40 | Ragged-red muscle fibers (HP:0003200) | 2.87540248 |
| 41 | Pili torti (HP:0003777) | 2.86632961 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.86503303 |
| 43 | Flat acetabular roof (HP:0003180) | 2.83601329 |
| 44 | Abnormality of vitamin metabolism (HP:0100508) | 2.83264115 |
| 45 | Abdominal distention (HP:0003270) | 2.81725691 |
| 46 | Popliteal pterygium (HP:0009756) | 2.76841320 |
| 47 | Partial duplication of thumb phalanx (HP:0009944) | 2.75896682 |
| 48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71937472 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 2.71937472 |
| 50 | Metabolic alkalosis (HP:0200114) | 2.70358274 |
| 51 | Reduced antithrombin III activity (HP:0001976) | 2.69692772 |
| 52 | Abnormality of urine glucose concentration (HP:0011016) | 2.69598924 |
| 53 | Glycosuria (HP:0003076) | 2.69598924 |
| 54 | Microretrognathia (HP:0000308) | 2.68911969 |
| 55 | Alkalosis (HP:0001948) | 2.64248005 |
| 56 | Astrocytoma (HP:0009592) | 2.64137243 |
| 57 | Abnormality of the astrocytes (HP:0100707) | 2.64137243 |
| 58 | Acanthocytosis (HP:0001927) | 2.59327277 |
| 59 | Nausea (HP:0002018) | 2.58582041 |
| 60 | Hypertriglyceridemia (HP:0002155) | 2.56468124 |
| 61 | Hypolipoproteinemia (HP:0010981) | 2.56039683 |
| 62 | Hypochromic anemia (HP:0001931) | 2.55884390 |
| 63 | Testicular atrophy (HP:0000029) | 2.55672006 |
| 64 | Abnormality of the costochondral junction (HP:0000919) | 2.54111489 |
| 65 | Acanthosis nigricans (HP:0000956) | 2.52882497 |
| 66 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.49980350 |
| 67 | Hypoplasia of the fovea (HP:0007750) | 2.49980350 |
| 68 | Bifid tongue (HP:0010297) | 2.45972778 |
| 69 | Chronic diarrhea (HP:0002028) | 2.45840833 |
| 70 | Anomalous pulmonary venous return (HP:0010772) | 2.45656903 |
| 71 | Hyperammonemia (HP:0001987) | 2.45435877 |
| 72 | Gout (HP:0001997) | 2.42624447 |
| 73 | Vaginal fistula (HP:0004320) | 2.40073417 |
| 74 | Pseudobulbar signs (HP:0002200) | 2.39737793 |
| 75 | Epidermoid cyst (HP:0200040) | 2.38074376 |
| 76 | Upper motor neuron abnormality (HP:0002127) | 2.37500840 |
| 77 | Abnormal hair laboratory examination (HP:0003328) | 2.36632057 |
| 78 | Partial duplication of the phalanx of hand (HP:0009999) | 2.36020975 |
| 79 | Enlarged epiphyses (HP:0010580) | 2.35720606 |
| 80 | Hypercholesterolemia (HP:0003124) | 2.34231443 |
| 81 | Abnormality of chloride homeostasis (HP:0011422) | 2.33834140 |
| 82 | Fused cervical vertebrae (HP:0002949) | 2.32895423 |
| 83 | Potter facies (HP:0002009) | 2.32725043 |
| 84 | Facial shape deformation (HP:0011334) | 2.32725043 |
| 85 | Megaloblastic anemia (HP:0001889) | 2.32408731 |
| 86 | Focal segmental glomerulosclerosis (HP:0000097) | 2.32224217 |
| 87 | Prolonged partial thromboplastin time (HP:0003645) | 2.30984997 |
| 88 | Akinesia (HP:0002304) | 2.30703671 |
| 89 | Proximal tubulopathy (HP:0000114) | 2.29380958 |
| 90 | Dicarboxylic aciduria (HP:0003215) | 2.28771631 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28771631 |
| 92 | Villous atrophy (HP:0011473) | 2.28556002 |
| 93 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.28556002 |
| 94 | Subcapsular cataract (HP:0000523) | 2.28227148 |
| 95 | Fat malabsorption (HP:0002630) | 2.28191909 |
| 96 | Neonatal onset (HP:0003623) | 2.28118616 |
| 97 | Hypophosphatemic rickets (HP:0004912) | 2.26677727 |
| 98 | Abnormal urine phosphate concentration (HP:0012599) | 2.25149567 |
| 99 | Hand muscle atrophy (HP:0009130) | 2.25082835 |
| 100 | Rectal fistula (HP:0100590) | 2.25004337 |
| 101 | Rectovaginal fistula (HP:0000143) | 2.25004337 |
| 102 | Hyponatremia (HP:0002902) | 2.24040795 |
| 103 | Hypoalbuminemia (HP:0003073) | 2.22751535 |
| 104 | Abnormal albumin level (HP:0012116) | 2.22751535 |
| 105 | Tetraplegia (HP:0002445) | 2.20237750 |
| 106 | Systemic lupus erythematosus (HP:0002725) | 2.19938855 |
| 107 | Joint hemorrhage (HP:0005261) | 2.19809873 |
| 108 | Peritonitis (HP:0002586) | 2.19309535 |
| 109 | Steatorrhea (HP:0002570) | 2.18843938 |
| 110 | Hypoalphalipoproteinemia (HP:0003233) | 2.18467999 |
| 111 | Increased purine levels (HP:0004368) | 2.12292703 |
| 112 | Hyperuricemia (HP:0002149) | 2.12292703 |
| 113 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.11637413 |
| 114 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11442544 |
| 115 | Curly hair (HP:0002212) | 2.11048431 |
| 116 | Alopecia of scalp (HP:0002293) | 2.09550720 |
| 117 | Congenital sensorineural hearing impairment (HP:0008527) | 2.06460523 |
| 118 | Abnormality of the pulmonary veins (HP:0011718) | 2.06123643 |
| 119 | Short humerus (HP:0005792) | 2.05679633 |
| 120 | Nephrolithiasis (HP:0000787) | 2.05673595 |
| 121 | Cheilitis (HP:0100825) | 2.05472055 |
| 122 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04698979 |
| 123 | Complement deficiency (HP:0004431) | 2.04140021 |
| 124 | Intestinal fistula (HP:0100819) | 2.03024371 |
| 125 | Hyperventilation (HP:0002883) | 2.02883939 |
| 126 | Pterygium (HP:0001059) | 2.02676037 |
| 127 | Periauricular skin pits (HP:0100277) | 2.02590224 |
| 128 | Preauricular pit (HP:0004467) | 2.02590224 |
| 129 | Hypophosphatemia (HP:0002148) | 2.01039995 |
| 130 | Glomerulosclerosis (HP:0000096) | 2.00244535 |
| 131 | Trismus (HP:0000211) | 1.99650190 |
| 132 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.99281432 |
| 133 | Short 5th finger (HP:0009237) | 1.99098709 |
| 134 | Rickets (HP:0002748) | 1.98283412 |
| 135 | Renal tubular dysfunction (HP:0000124) | 1.97342433 |
| 136 | Skin pits (HP:0100276) | 1.92917749 |
| 137 | Ketosis (HP:0001946) | 1.92876080 |
| 138 | Bronchomalacia (HP:0002780) | 1.92153219 |
| 139 | Hyperaldosteronism (HP:0000859) | 1.91308247 |
| 140 | Embryonal renal neoplasm (HP:0011794) | 1.90802678 |
| 141 | Late onset (HP:0003584) | 1.90396122 |
| 142 | Growth hormone excess (HP:0000845) | 1.90206199 |
| 143 | Hypotension (HP:0002615) | 1.90052049 |
| 144 | Gastrointestinal dysmotility (HP:0002579) | 1.88538544 |
| 145 | Hyperphosphaturia (HP:0003109) | 1.87971896 |
| 146 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.87896551 |
| 147 | Amyloidosis (HP:0011034) | 1.87667129 |
| 148 | Preauricular skin tag (HP:0000384) | 1.86879367 |
| 149 | Ulnar bowing (HP:0003031) | 1.85757654 |
| 150 | Shawl scrotum (HP:0000049) | 1.85150494 |
| 151 | Insulin resistance (HP:0000855) | 1.85130312 |
| 152 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85121997 |
| 153 | Increased muscle lipid content (HP:0009058) | 1.84352636 |
| 154 | Coronal craniosynostosis (HP:0004440) | 1.84283155 |
| 155 | Large earlobe (HP:0009748) | 1.83723564 |
| 156 | Hyperparathyroidism (HP:0000843) | 1.83444654 |
| 157 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.83422124 |
| 158 | Abnormality of the Achilles tendon (HP:0005109) | 1.83209159 |
| 159 | Metabolic acidosis (HP:0001942) | 1.82506349 |
| 160 | Abnormality of nucleobase metabolism (HP:0010932) | 1.82349298 |
| 161 | Amyotrophic lateral sclerosis (HP:0007354) | 1.81254851 |
| 162 | Hyperlipoproteinemia (HP:0010980) | 1.80916177 |
| 163 | Abnormality of the musculature of the hand (HP:0001421) | 1.80897439 |
| 164 | Abnormal tarsal ossification (HP:0008369) | 1.80800543 |
| 165 | Horizontal nystagmus (HP:0000666) | 1.79903927 |
| 166 | Conjugated hyperbilirubinemia (HP:0002908) | 1.79866765 |
| 167 | Glioma (HP:0009733) | 1.78990829 |
| 168 | Neoplasm of the oral cavity (HP:0100649) | 1.78486381 |
| 169 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.78096129 |
| 170 | Hypoplastic scapulae (HP:0000882) | 1.78096129 |
| 171 | Hyperglycinemia (HP:0002154) | 1.77322044 |
| 172 | Distal upper limb amyotrophy (HP:0007149) | 1.75565435 |
| 173 | Upper limb amyotrophy (HP:0009129) | 1.75565435 |
| 174 | Abnormality of purine metabolism (HP:0004352) | 1.75474301 |
| 175 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.74557642 |
| 176 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.74529578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 6.97162223 |
| 2 | ERN1 | 5.47827747 |
| 3 | GRK5 | 4.36841994 |
| 4 | GRK6 | 4.31624130 |
| 5 | ACVR1B | 3.91328698 |
| 6 | GRK1 | 3.25329813 |
| 7 | STK10 | 2.91098934 |
| 8 | TGFBR2 | 2.71447238 |
| 9 | MATK | 2.67548871 |
| 10 | MAPK15 | 2.66595631 |
| 11 | ADRBK2 | 2.55504868 |
| 12 | LMTK2 | 2.51126095 |
| 13 | CSF1R | 2.45981021 |
| 14 | MAP2K4 | 2.17950223 |
| 15 | MAPK7 | 2.16529270 |
| 16 | EPHA2 | 2.13839554 |
| 17 | MAP2K6 | 2.09140863 |
| 18 | STK39 | 2.08557643 |
| 19 | MAP2K3 | 1.97641239 |
| 20 | TTK | 1.85329731 |
| 21 | GRK7 | 1.84409077 |
| 22 | EPHB2 | 1.80976898 |
| 23 | TYRO3 | 1.80963569 |
| 24 | WNK4 | 1.78329568 |
| 25 | MAP3K6 | 1.71357456 |
| 26 | PRKG2 | 1.69467833 |
| 27 | MOS | 1.48187585 |
| 28 | TESK2 | 1.44760745 |
| 29 | PIK3CA | 1.44686062 |
| 30 | PDK2 | 1.44170891 |
| 31 | MAP3K10 | 1.40398744 |
| 32 | MAP3K2 | 1.39206230 |
| 33 | SIK1 | 1.35633312 |
| 34 | MAP3K7 | 1.33323146 |
| 35 | RIPK1 | 1.30056150 |
| 36 | CAMK4 | 1.27963390 |
| 37 | MARK2 | 1.25470854 |
| 38 | TIE1 | 1.22342485 |
| 39 | AKT3 | 1.19480255 |
| 40 | OXSR1 | 1.17081191 |
| 41 | NTRK1 | 1.13199111 |
| 42 | WNK1 | 1.13070605 |
| 43 | PDPK1 | 1.11221485 |
| 44 | PAK4 | 1.10626634 |
| 45 | EPHB1 | 1.08725318 |
| 46 | NME1 | 1.08669574 |
| 47 | BCKDK | 1.07641715 |
| 48 | ADRBK1 | 1.07221038 |
| 49 | SMG1 | 1.06552320 |
| 50 | CDK7 | 1.05339458 |
| 51 | STK24 | 1.03908984 |
| 52 | MST1R | 1.01901627 |
| 53 | FGFR3 | 0.99969146 |
| 54 | PBK | 0.98409477 |
| 55 | FER | 0.96894832 |
| 56 | TESK1 | 0.96724264 |
| 57 | CSK | 0.85990209 |
| 58 | IRAK3 | 0.85887035 |
| 59 | MUSK | 0.84331783 |
| 60 | HIPK2 | 0.83633812 |
| 61 | PTK2 | 0.83293948 |
| 62 | BMX | 0.77529465 |
| 63 | TNIK | 0.73522155 |
| 64 | NLK | 0.69965059 |
| 65 | CDK6 | 0.69287048 |
| 66 | TLK1 | 0.67883565 |
| 67 | MAP3K1 | 0.66919101 |
| 68 | EEF2K | 0.66135359 |
| 69 | CHEK2 | 0.65834287 |
| 70 | IRAK2 | 0.64746211 |
| 71 | TRIB3 | 0.64318053 |
| 72 | LATS1 | 0.63851854 |
| 73 | PRKCI | 0.63451498 |
| 74 | FGFR4 | 0.63149660 |
| 75 | ERBB2 | 0.63024951 |
| 76 | MAPK12 | 0.62065152 |
| 77 | MAP3K3 | 0.61006909 |
| 78 | CDC42BPA | 0.59837215 |
| 79 | AKT2 | 0.59325763 |
| 80 | STK38L | 0.58898196 |
| 81 | MYLK | 0.58200066 |
| 82 | MST4 | 0.57282866 |
| 83 | LATS2 | 0.54738703 |
| 84 | MAP3K12 | 0.54643216 |
| 85 | EPHA3 | 0.52511722 |
| 86 | RPS6KB2 | 0.52310601 |
| 87 | MTOR | 0.52293705 |
| 88 | IGF1R | 0.51456844 |
| 89 | PRKD2 | 0.51375814 |
| 90 | MAP2K1 | 0.48873189 |
| 91 | TAOK1 | 0.48193378 |
| 92 | FRK | 0.47921095 |
| 93 | MAP2K2 | 0.47306046 |
| 94 | IRAK1 | 0.47062228 |
| 95 | MAPK4 | 0.46995083 |
| 96 | PTK6 | 0.45714289 |
| 97 | EIF2AK2 | 0.43298487 |
| 98 | IKBKB | 0.43247610 |
| 99 | ABL2 | 0.41259755 |
| 100 | MELK | 0.40692143 |
| 101 | STK3 | 0.40007982 |
| 102 | ALK | 0.39833669 |
| 103 | KIT | 0.39765001 |
| 104 | ERBB4 | 0.39303619 |
| 105 | CAMK1D | 0.38897351 |
| 106 | NEK6 | 0.38594341 |
| 107 | MET | 0.38401517 |
| 108 | STK38 | 0.36648418 |
| 109 | PRKAA2 | 0.34907485 |
| 110 | PDK1 | 0.34416324 |
| 111 | ITK | 0.34392981 |
| 112 | PRKCD | 0.33433203 |
| 113 | FLT3 | 0.33086906 |
| 114 | TBK1 | 0.32708772 |
| 115 | SRC | 0.30996621 |
| 116 | BLK | 0.30435248 |
| 117 | ZAP70 | 0.30076619 |
| 118 | PKN2 | 0.29795216 |
| 119 | YES1 | 0.29376550 |
| 120 | PIK3CG | 0.27927218 |
| 121 | PRKAA1 | 0.27220182 |
| 122 | INSRR | 0.26658187 |
| 123 | PRKACG | 0.25866259 |
| 124 | RET | 0.24608102 |
| 125 | GSK3A | 0.24482552 |
| 126 | PRKCZ | 0.24478700 |
| 127 | JAK2 | 0.24128866 |
| 128 | ICK | 0.24086594 |
| 129 | TAOK3 | 0.23735424 |
| 130 | PDGFRA | 0.23554820 |
| 131 | MAP3K11 | 0.22983514 |
| 132 | TYK2 | 0.22471301 |
| 133 | ZAK | 0.21515191 |
| 134 | CHUK | 0.21511414 |
| 135 | DYRK1B | 0.21463065 |
| 136 | INSR | 0.21301910 |
| 137 | DDR2 | 0.21063962 |
| 138 | LRRK2 | 0.19780339 |
| 139 | PRKCA | 0.19372616 |
| 140 | CHEK1 | 0.19161592 |
| 141 | RPS6KA2 | 0.19120337 |
| 142 | MAP3K5 | 0.18962450 |
| 143 | MAPK11 | 0.18637755 |
| 144 | CAMK2D | 0.18547242 |
| 145 | CSNK1A1 | 0.17999310 |
| 146 | MAPK1 | 0.17969722 |
| 147 | PAK3 | 0.17574468 |
| 148 | * PLK1 | 0.15713525 |
| 149 | TAOK2 | 0.13258074 |
| 150 | CDK4 | 0.13013023 |
| 151 | ABL1 | 0.12334188 |
| 152 | MAPKAPK3 | 0.12294221 |
| 153 | MARK3 | 0.12071421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.46763624 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.95687298 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.95338533 |
| 4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.93832050 |
| 5 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.83523964 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.78037453 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.53021462 |
| 8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.46002523 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 2.28709787 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.28405186 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.22488223 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.14801090 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.10650724 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.09216087 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.06247997 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.05715806 |
| 17 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.96092110 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94336535 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86821675 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.85428777 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82861635 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.77310636 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74146677 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.70943238 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70008850 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.68266363 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.67807356 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.66724870 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.64020747 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62543411 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.57090341 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.46412613 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.45497176 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.43239858 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.40759338 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38811003 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37620800 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37618847 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.37129352 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25376013 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20248261 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19237799 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18463349 |
| 44 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.17184416 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10370787 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09607324 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.08879408 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07292048 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06971238 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04148515 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03877138 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03066105 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01871595 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.00436848 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00182432 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.96210396 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92750654 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88266068 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83829386 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.83358145 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81290141 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80703926 |
| 63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79159516 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75001475 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70249881 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67019664 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65890662 |
| 68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.65877866 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64696811 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64344288 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63109452 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.62005500 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58946013 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56773274 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55747891 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55644704 |
| 77 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53802393 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53163175 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52988130 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51086503 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.49304841 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48414632 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46041033 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44545253 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43268996 |
| 86 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43112881 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38220368 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37641529 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37439947 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34829308 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33336808 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31544544 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30597062 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30576178 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30548117 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28755271 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28686973 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.25773111 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25769014 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25768140 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24130447 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24021600 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.23702410 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.23449979 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.23022006 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22535182 |
| 107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.20012049 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.19150459 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18246354 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16154947 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13626327 |
| 112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.13071747 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.12520872 |
| 114 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.12215102 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.11658517 |
| 116 | Renin secretion_Homo sapiens_hsa04924 | 0.09601937 |

